In today’s session Herbalife Ltd. (HLF) registered an unusually high (1,004) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the November, 2016 call, expecting serious HLF increase. With 1,004 contracts traded and 108494 open interest for the Nov, 16 contract, it seems this is a quite bullish bet. The option with symbol: HLF161118C00065000 closed last at: $3.1 or 0% . About 868,651 shares traded hands. Herbalife Ltd. (NYSE:HLF) has risen 13.69% since March 1, 2016 and is uptrending. It has outperformed by 4.45% the S&P500.
Analysts await Herbalife Ltd. (NYSE:HLF) to report earnings on November, 1. They expect $1.08 earnings per share, down 15.63% or $0.20 from last year’s $1.28 per share. HLF’s profit will be $103.48M for 14.66 P/E if the $1.08 EPS becomes a reality. After $1.29 actual earnings per share reported by Herbalife Ltd. for the previous quarter, Wall Street now forecasts -16.28% negative EPS growth.
Herbalife Ltd. (NYSE:HLF) Ratings Coverage
Out of 3 analysts covering Herbalife (NYSE:HLF), 2 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 67% are positive. $100.0 is the highest target while $54.88 is the lowest. The $66.78 average target is 5.41% above today’s ($63.35) stock price. Herbalife has been the topic of 10 analyst reports since August 6, 2015 according to StockzIntelligence Inc. Zacks upgraded Herbalife Ltd. (NYSE:HLF) rating on Friday, August 7. Zacks has “Hold” rating and $67 price target. The stock of Herbalife Ltd. (NYSE:HLF) has “Buy” rating given on Friday, August 7 by Vetr. As per Tuesday, August 4, the company rating was maintained by Barclays Capital. The firm has “Buy” rating by Pivotal Research given on Tuesday, August 4. Pivotal Research maintained Herbalife Ltd. (NYSE:HLF) rating on Wednesday, November 4. Pivotal Research has “Buy” rating and $85 price target. The rating was maintained by Pivotal Research on Thursday, August 27 with “Buy”. The firm has “Neutral” rating given on Tuesday, July 21 by Sterne Agee CRT. Vetr downgraded it to “Buy” rating and $56.92 target price in Monday, August 31 report.
Insitutional Activity: The institutional sentiment decreased to 1.29 in Q2 2016. Its down 0.03, from 1.32 in 2016Q1. The ratio dropped, as 23 funds sold all Herbalife Ltd. shares owned while 71 reduced positions. 39 funds bought stakes while 82 increased positions. They now own 87.76 million shares or 3.47% less from 90.91 million shares in 2016Q1.
The California-based California Public Employees Retirement Sys has invested 0.03% in Herbalife Ltd. (NYSE:HLF). Moreover, Lsv Asset Mngmt has 0% invested in Herbalife Ltd. (NYSE:HLF) for 5,400 shares. Moreover, Bnp Paribas Inv Prtn has 0% invested in Herbalife Ltd. (NYSE:HLF) for 4,959 shares. Cibc Asset Management Inc last reported 0% of its portfolio in the stock. Nuveen Asset Management Lc has 0.06% invested in the company for 168,584 shares. Ubs Asset Mngmt Americas, a Illinois-based fund reported 82,827 shares. Brandywine Glob Mgmt Ltd Company last reported 380,139 shares in the company. Nationwide Fund Advsr has 2,166 shares for 0% of their US portfolio. Voya Mgmt Ltd Liability Corporation reported 31,994 shares or 0% of all its holdings. Jensen Mngmt reported 6,590 shares or 0.01% of all its holdings. Utd Cap Advisers Limited accumulated 0% or 4,497 shares. Allianz Asset Mngmt Ag last reported 0% of its portfolio in the stock. Legal General Public Lc, a United Kingdom-based fund reported 338,432 shares. Commerzbank Aktiengesellschaft Fi accumulated 74,096 shares or 0.03% of the stock. Partners Ltd Liability owns 2.63M shares or 14.92% of their US portfolio.
Herbalife Ltd. is a global nutrition company. The company has a market cap of $6.07 billion. The Firm develops and sells weight management, healthy meals and snacks, sports and fitness, energy and targeted nutritional products, as well as personal care products. It has a 21.74 P/E ratio. The Company’s divisions include North America; Mexico; South & Central America; Europe, Middle East, and Africa ; Asia Pacific, and China.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.